The Women's Health Diagnostics Market size is forecast to reach $27.18 billion by 2025, growing at a CAGR of 6.83% during the forecast period 2020-2025. Growing awareness about various health-related disorders among Women’s, rising incidence of various chronic diseases and high prevalence of infectious diseases such as HIV and hepatitis in Women’s is the major factor driving the growth of the market. High adoption of point-of-care diagnostics and availability of newer and advanced diagnostic systems is set to further enhance the overall market demand for the Women's Health Diagnostics Market during the forecast period 2020-2025.
Women's Health Diagnostics Market Report Coverage
The report: “Women's Health Diagnostics Market Forecast (2020-2025)”, by IndustryARC, covers an in-depth analysis of the following segments of the Women's Health Diagnostics Market.
By Diagnostic Devices: Biopsy Device, Imaging & Monitoring System, Ultrasound Devices, Mammography System, MRI Systems, and Nuclear Imaging
By Diagnostic Test: Breast Cancer Testing, Cervical Cancer Testing, Prenatal Genetic Screening & Carrier Testing, Pregnancy & Ovulation Testing, Ovarian Cancer Testing, and Colonoscopy
By Disease: Hyperthyroidism, Osteoporosis, Pre Eclampsia, and Others
By End User: Hospitals & Clinics, Home Care Settings, Diagnostic & Imaging Centers, and Others
By Geography: North America, Europe, Asia Pacific, and Rest of the World (RoW)
Request Sample
Key Takeaways
- North America dominated the Women's Health Diagnostics Market in 2019 owing to the high adoption of technologically advanced products, product launches by the key companies present in this region and government initiatives. The Women's Health Diagnostics Market scope for different regions will be provided in the final report.
- The presence of better healthcare infrastructure and rising awareness about Women's health disorders is likely to aid in the market growth of the Women's Health Diagnostics Market.
- Detailed analysis of the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Women's Health Diagnostics Market report.
- Shortage of skilled laboratory technicians and high costs of diagnostics devices, tests, and procedures are poise to create hurdles for the Women's Health Diagnostics Market.
Women's Health Diagnostics Market Segment Analysis - By Diagnostic Test
The Breast Cancer Testing segment held the largest share in the Women's Health Diagnostics Market in 2019 and is estimated to grow at a CAGR of 7.4% during the forecast period 2020-2025. Breast cancer is cancer that forms in the cells of the breasts. After skin cancer, breast cancer is the most common cancer diagnosed in Women's. Breast cancer can occur in both men and Women's, but it's far more common in Women's. Substantial support for breast cancer awareness and research funding has helped create advances in the diagnosis and treatment of breast cancer. Breast cancer survival rates have increased, and the number of deaths associated with this disease is steadily declining, largely owing to factors such as earlier detection, a new personalized approach to treatment, and a better understanding of the disease. Ultrasonic devices are used to detect objects and measure distances. Ultrasound imaging or sonography is often used in medicine. In the non-destructive testing of products and structures, ultrasound is used to detect invisible flaws. Breast Cancer Testing is set to be the highest growing segment and is estimated to register the highest CAGR during the forecast period 2020-2025.
Schedule a Call
Women's Health Diagnostics Market Segment Analysis - By End User
The Hospitals & clinics segment held the largest share in the Women's Health Diagnostics Market in 2019 owing to increasing investments by market players in hospitals & clinics to commercialize portable and point of care devices. Women are increasingly seeking unconventional birth settings that are focused on a more natural, human experience. Alternative birth settings within hospitals such as home-like, ambient, and snoezelen rooms, are associated with fewer medical interventions during labour and greater patient satisfaction, with no increased risk to the mother or infant. Hospitals & Clinics are set to be the highest growing segment and are estimated to register the highest CAGR during the forecast period 2020-2025.
Women's Health Diagnostics Market Segment Analysis - By Geography
North America dominated the Women's Health Diagnostics Market in 2019 with a share of more than 41.7%, followed by the Asia Pacific owing to the increasing prevalence of cancer among Women's. Increasing incidence of health disorders, growing focus of manufacturers of Women’s health diagnostic products on expanding their presence in this region, and increasing demand for fertility testing monitors is also increasing the growth of the Women's Health Diagnostics Market in this region.
However, Asia Pacific is estimated to grow at a higher CAGR during the forecast period 2020-2025 owing to the improving healthcare infrastructure, rising awareness about Women’s health disorders, government initiatives, and increased participation of Women's in the workforce.
Women's Health Diagnostics Market Drivers
- High prevalence of infectious diseases such as HIV and hepatitis in Women’s
The high prevalence of infectious diseases such as HIV and hepatitis in Women’s is increasing the growth of the Women’s Health Diagnostics Market. HIV/AIDS and malaria, along with tuberculosis, continue to disproportionately affect and further weaken the condition of Women's.HIV infection in Women’s has obvious implications for the health and wellbeing of children. HIV infection can be transmitted prenatally, and increasing numbers of children are orphaned by the disease. Although preventing HIV transmission from an infected mother to her infant has become feasible owing to effective antiretroviral treatment regimens and has met with great success in many parts of the world, services that prevent mother-to-child transmission are severely limited in low-income countries. Thus, increasing the growth of the Women’s Health Diagnostics Market during the forecast period 2020-2025.
- Rising awareness about Women's health disorders
Rising awareness about Women’s health disorders is increasing the growth of the Women's Health Diagnostics Market. Women’s health encompasses a continuum of biological, psychological, and social challenges that differ considerably from those of men. Though Women’s health often is the focus of diseases such as breast and ovarian cancers and those of the reproductive system, it is, in fact, a much more encompassing field. The risks for heart disease include high blood pressure, high cholesterol, diabetes, obesity, smoking, poor diet, and lack of physical exercise. Thus, increasing the growth of the Women's Health Diagnostics Market during the forecast period 2020-2025.
Women's Health Diagnostics Market Challenges
- Shortage of skilled laboratory technicians and high costs of diagnostics devices, tests, and procedures
Some of the factors that are set to impede the growth of the Women's Health Diagnostics Market are a shortage of skilled laboratory technicians and high costs of diagnostics devices, tests, and procedures.
Women's Health Diagnostics Market Industry Outlook
Product launches, mergers and acquisitions, joint ventures, and R&D activities are key strategies adopted by players in the Women's Health Diagnostics Market. In 2019, the Women's Health Diagnostics Market share is consolidated by the top ten players present in the market. Women's Health Diagnostics Market, the top 10 companies are Cardinal Health, Siemens, Hologic, Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Abbott, BD, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Koninklijke Philips N.V., NeuroLogica Corp., Shimadzu Corporation among others.
Acquisitions/Product Launches
- In May 2019, Cardinal Health announced the launch of its RADIAL 360 portfolio in the U.S. With this there is an increase product portfolio that provides a complete range of products for Trans Radial Approach (TRA) for interventional cardiology procedures.
- In May 2019, Roche launched the VENTANA HER2 Dual ISH DNA Probe Cocktail assay for detecting the HER2 biomarker in gastric and breast cancer. This would help in enhancing the product portfolio of the company
For more Lifesciences and Healthcare related reports, please click here
Post a Comment